These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8475501

  • 1. Reduction of hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is due to decreased mRNA levels.
    Stahl BU, Beer DG, Weber LW, Rozman K.
    Toxicology; 1993 Mar 30; 79(1):81-95. PubMed ID: 8475501
    [Abstract] [Full Text] [Related]

  • 2. Decreased hepatic phosphoenolpyruvate carboxykinase gene expression after 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment: implications for the acute toxicity of chlorinated dibenzo-p-dioxins in the rat.
    Stahl BU, Beer DG, Weber LW, Lebofsky M, Rozman K.
    Arch Toxicol Suppl; 1992 Mar 30; 15():151-5. PubMed ID: 1510582
    [Abstract] [Full Text] [Related]

  • 3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks the physiological regulation of hepatic phosphoenolpyruvate carboxykinase activity in primary rat hepatocytes.
    Stahl BU.
    Toxicology; 1995 Nov 20; 103(1):45-52. PubMed ID: 8525489
    [Abstract] [Full Text] [Related]

  • 4. Subchronic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and their reversibility in male Sprague-Dawley rats.
    Li X, Rozman KK.
    Toxicology; 1995 Mar 31; 97(1-3):133-40. PubMed ID: 7716779
    [Abstract] [Full Text] [Related]

  • 5. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDD-susceptible and the most TCDD-resistant rat strains.
    Viluksela M, Unkila M, Pohjanvirta R, Tuomisto JT, Stahl BU, Rozman KK, Tuomisto J.
    Arch Toxicol; 1999 Aug 31; 73(6):323-36. PubMed ID: 10447560
    [Abstract] [Full Text] [Related]

  • 6. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice.
    Weber LW, Lebofsky M, Stahl BU, Smith S, Rozman KK.
    Toxicol Appl Pharmacol; 1995 Mar 31; 131(1):155-62. PubMed ID: 7878671
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Short- and long-term biochemical effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Long-Evans rats.
    Fan F, Rozman KK.
    Toxicol Lett; 1995 Jan 31; 75(1-3):209-16. PubMed ID: 7863529
    [Abstract] [Full Text] [Related]

  • 9. Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats.
    Weber LW, Lebofsky M, Stahl BU, Gorski JR, Muzi G, Rozman K.
    Toxicology; 1991 Feb 31; 66(2):133-44. PubMed ID: 1849669
    [Abstract] [Full Text] [Related]

  • 10. Relationship between acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and disturbance of intermediary metabolism in the Long-Evans rat.
    Fan F, Rozman KK.
    Arch Toxicol; 1994 Feb 31; 69(2):73-8. PubMed ID: 7717864
    [Abstract] [Full Text] [Related]

  • 11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin (HxCDD) alter body weight by decreasing insulin-like growth factor I (IGF-I) signaling.
    Croutch CR, Lebofsky M, Schramm KW, Terranova PF, Rozman KK.
    Toxicol Sci; 2005 May 31; 85(1):560-71. PubMed ID: 15703265
    [Abstract] [Full Text] [Related]

  • 12. Induction of ethoxyresorufin-O-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Stohs SJ, Abbott BD, Lin FH, Birnbaum LS.
    Toxicology; 1990 Dec 17; 65(1-2):123-36. PubMed ID: 2274963
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo-p-dioxins in rats. II. Biochemical effects.
    Viluksela M, Stahl BU, Birnbaum LS, Rozman KK.
    Toxicol Appl Pharmacol; 1998 Jul 17; 151(1):70-8. PubMed ID: 9705888
    [Abstract] [Full Text] [Related]

  • 15. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
    Vanden Heuvel JP, Clark GC, Kohn MC, Tritscher AM, Greenlee WF, Lucier GW, Bell DA.
    Cancer Res; 1994 Jan 01; 54(1):62-8. PubMed ID: 8261464
    [Abstract] [Full Text] [Related]

  • 16. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    DeVito MJ, Beebe LE, Menache M, Birnbaum LS.
    J Toxicol Environ Health; 1996 Mar 01; 47(4):379-94. PubMed ID: 8600290
    [Abstract] [Full Text] [Related]

  • 17. Key enzymes of gluconeogenesis are dose-dependently reduced in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.
    Weber LW, Lebofsky M, Greim H, Rozman K.
    Arch Toxicol; 1991 Mar 01; 65(2):119-23. PubMed ID: 2059151
    [Abstract] [Full Text] [Related]

  • 18. Subchronic/chronic toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) in rats. Part II. Biochemical effects.
    Viluksela M, Stahl BU, Birnbaum LS, Rozman KK.
    Toxicol Appl Pharmacol; 1997 Oct 01; 146(2):217-26. PubMed ID: 9344889
    [Abstract] [Full Text] [Related]

  • 19. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
    Shen ES, Guengerich FP, Olson JR.
    Biochem Pharmacol; 1989 Nov 15; 38(22):4075-84. PubMed ID: 2512931
    [Abstract] [Full Text] [Related]

  • 20. Sepsis-induced alterations in phosphoenolpyruvate carboxykinase expression: the role of insulin and glucagon.
    Deutschman CS, De Maio A, Buchman TG, Clemens MG.
    Circ Shock; 1993 Aug 15; 40(4):295-302. PubMed ID: 8375031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.